Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$921K Sell
1,000
-378
-27% -$312K ﹤0.01% 1467
2026
Q1
$1.01M Sell
1,378
-519
-27% -$406K 0.01% 1293
2025
Q4
$1.6M Buy
1,897
+441
+30% +$377K 0.01% 971
2025
Q3
$1.08M Buy
1,456
+69
+5% +$45.5K 0.01% 1051
2025
Q2
$765K Sell
1,387
-155
-10% -$90K 0.01% 1126
2025
Q1
$908K Buy
1,542
+376
+32% +$237K 0.01% 872
2024
Q4
$726K Buy
1,166
+413
+55% +$242K 0.01% 900
2024
Q3
$408K Buy
753
+273
+57% +$138K 0.01% 954
2024
Q2
$206K Buy
+480
New +$184K 0.01% 840

Other funds holding ARGX

&Partners's ARGX Position: Q2 2026 in Review

&Partners reduced its argenx (ARGX) stake by 27% in Q2 2026, selling an estimated $312K and leaving 1,000 shares worth $921K. The position accounts for ﹤0.01% of the portfolio, ranked #1467.

&Partners first reported a position in ARGX in Q2 2024 and has held it in 9 quarters since. The position peaked at $1.6M in Q4 2025. 505 funds tracked by Wall St. Rank hold ARGX as of Q2 2026.

  • &Partners held 1,000 shares of argenx worth $921K as of Q2 2026.
  • &Partners sold 378 argenx shares in Q2 2026, an estimated $312K.
  • argenx made up ﹤0.01% of &Partners's portfolio in Q2 2026, its #1467 holding.
  • &Partners first reported a position in argenx in Q2 2024 and has held it in 9 quarters since.
  • &Partners's argenx position peaked at $1.6M in Q4 2025.
  • 505 funds tracked by Wall St. Rank held argenx as of Q2 2026.

Based on &Partners's 13F filing for Q2 2026, filed 14 Aug 2026.